Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
39.8M
-
Shares change
-
-343K
-
Total reported value, excl. options
-
$1.33B
-
Value change
-
+$20.6M
-
Put/Call ratio
-
0.48
-
Number of buys
-
83
-
Number of sells
-
-36
-
Price
-
$33.33
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q3 2024
135 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q3 2024.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.8M shares
.
Largest 10 shareholders include FMR LLC (4.35M shares), FARALLON CAPITAL MANAGEMENT LLC (3.15M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.91M shares), BlackRock, Inc. (2.84M shares), Cormorant Asset Management, LP (2.79M shares), VANGUARD GROUP INC (2.03M shares), VIKING GLOBAL INVESTORS LP (1.97M shares), WELLINGTON MANAGEMENT GROUP LLP (1.59M shares), Polar Capital Holdings Plc (1.1M shares), and Integral Health Asset Management, LLC (1.05M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.